background image

Paid Clinical Trials Murfreesboro

Discover 1,219 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Survodutide

Recruiting
PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Nashville, Clarksville, Chattanooga, Louisvilleshow 106 more

Code:

NCT06632444

Conditions

Metabolic Dysfunction Associated Steatohepatitis (MASH)

Liver Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo

Dato-DXd & Rilvegostomig

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Nashville, Knoxville, Lexington, Memphisshow 68 more

Code:

NCT06564844

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Datopotamab Deruxtecan

Rilvegostomig

Carboplatin

Cisplatin

Etoposide

CRB-601-01

Recruiting
PHASE1
PHASE2

Sponsor:

Corbus Pharmaceuticals Inc.

Location:

Nashville, Birmingham, Roanoke, Durhamshow 14 more

Code:

NCT06603844

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CRB-601 monoclonal antibody

Anti-PD-1 monoclonal antibody

Immune-priming single lesion SBRT

Neuroblastoma

Recruiting
PHASE2

Sponsor:

Giselle Sholler

Location:

Nashville, Birmingham, Louisville, Lexingtonshow 42 more

Code:

NCT02679144

Conditions

Neuroblastoma

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Difluoromethylornithine (DFMO)

Observational Study

Recruiting

Sponsor:

Children's Oncology Group

Location:

Nashville, Chattanooga, Knoxville, Birminghamshow 167 more

Code:

NCT02402244

Conditions

Adrenal Gland Pheochromocytoma

Carcinoma In Situ

Central Nervous System Neoplasm

Childhood Immature Teratoma

Childhood Langerhans Cell Histiocytosis

Eligibility Criteria

Sex: All

Age: 0 - 25

Healthy Volunteers: Not accepted

Interventions

Cytology Specimen Collection Procedure

Medical Chart Review

JAK Inhibitors

Recruiting
PHASE2

Sponsor:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Location:

Nashville, Atlanta, Indianapolis, Pittsburghshow 16 more

Code:

NCT05743244

Conditions

Diabetes Mellitus, Type 1

Eligibility Criteria

Sex: All

Age: 12 - 35

Healthy Volunteers: Not accepted

Interventions

Abrocitinib 200 MG Oral Tablet

Ritlecitinib

Placebo

Observational Study

Recruiting

Sponsor:

Edwards Lifesciences

Location:

Nashville, Huntsville, Atlanta, Cincinnatishow 47 more

Code:

NCT04153292

Conditions

Mitral Regurgitation

Mitral Valve Insufficiency

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SAPIEN M3 valve and dock

Tradipitant

Recruiting
PHASE3

Sponsor:

Vanda Pharmaceuticals

Location:

Nashville, Chattanooga, Birmingham, Louisvilleshow 29 more

Code:

NCT04028492

Conditions

Idiopathic Gastroparesis

Diabetic Gastroparesis

Gastroparesis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Tradipitant

Placebo

Open Label Tradipitant

PRECardiovascular & Diabetic Kidney Disease

Recruiting

Sponsor:

Brigham and Women's Hospital

Location:

Nashville, Columbia, Durham, Charlestonshow 4 more

Code:

NCT05390892

Conditions

Type2Diabetes

ASCVD

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

SGLT2 inhibitor

GLP-1 receptor agonist

Revascularization Choices

Recruiting
PHASE3

Sponsor:

Weill Medical College of Cornell University

Location:

Nashville, Atlanta, Memphis, Carmelshow 7 more

Code:

NCT06399692

Conditions

Coronary Artery Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Coronary artery bypass grafting (CABG)

Percutaneous coronary intervention (PCI)